These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 19682434

  • 21. Replication-competent adenovirus expressing TRAIL synergistically potentiates the antitumor effect of gemcitabine in bladder cancer cells.
    Mao L, Yang C, Li L, Nai L, Fan L, Wang J, Li W, Wen R, Chen J, Zheng J.
    Tumour Biol; 2014 Jun; 35(6):5937-44. PubMed ID: 24604329
    [Abstract] [Full Text] [Related]

  • 22. Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells.
    Yu Y, Wang J, Xia N, Li B, Jiang X.
    Oncol Rep; 2015 Apr; 33(4):1683-90. PubMed ID: 25633045
    [Abstract] [Full Text] [Related]

  • 23. Curcumin enhances anti‑cancer efficacy of either gemcitabine or docetaxel on pancreatic cancer cells.
    Liu P, Ying Q, Liu H, Yu SQ, Bu LP, Shao L, Li XY.
    Oncol Rep; 2020 Oct; 44(4):1393-1402. PubMed ID: 32945513
    [Abstract] [Full Text] [Related]

  • 24. Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets.
    Park B, Prasad S, Yadav V, Sung B, Aggarwal BB.
    PLoS One; 2011 Oct; 6(10):e26943. PubMed ID: 22066019
    [Abstract] [Full Text] [Related]

  • 25. Targeting Casein Kinase 1 Delta Sensitizes Pancreatic and Bladder Cancer Cells to Gemcitabine Treatment by Upregulating Deoxycytidine Kinase.
    Vena F, Bayle S, Nieto A, Quereda V, Aceti M, Frydman SM, Sansil SS, Grant W, Monastyrskyi A, McDonald P, Roush WR, Teng M, Duckett D.
    Mol Cancer Ther; 2020 Aug; 19(8):1623-1635. PubMed ID: 32430484
    [Abstract] [Full Text] [Related]

  • 26. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway.
    Lin YG, Kunnumakkara AB, Nair A, Merritt WM, Han LY, Armaiz-Pena GN, Kamat AA, Spannuth WA, Gershenson DM, Lutgendorf SK, Aggarwal BB, Sood AK.
    Clin Cancer Res; 2007 Jun 01; 13(11):3423-30. PubMed ID: 17545551
    [Abstract] [Full Text] [Related]

  • 27. Curcumin inhibits tumor growth and angiogenesis in an orthotopic mouse model of human pancreatic cancer.
    Bimonte S, Barbieri A, Palma G, Luciano A, Rea D, Arra C.
    Biomed Res Int; 2013 Jun 01; 2013():810423. PubMed ID: 24324975
    [Abstract] [Full Text] [Related]

  • 28. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer.
    Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, Chiao PJ, Philip PA, Abbruzzese J, Sarkar FH.
    Cancer Res; 2005 Oct 01; 65(19):9064-72. PubMed ID: 16204081
    [Abstract] [Full Text] [Related]

  • 29. Everolimus enhances gemcitabine-induced cytotoxicity in bladder-cancer cell lines.
    Pinto-Leite R, Arantes-Rodrigues R, Palmeira C, Gaivão I, Cardoso ML, Colaço A, Santos L, Oliveira P.
    J Toxicol Environ Health A; 2012 Oct 01; 75(13-15):788-99. PubMed ID: 22788366
    [Abstract] [Full Text] [Related]

  • 30. Antiangiogenic treatment with three thrombospondin-1 type 1 repeats versus gemcitabine in an orthotopic human pancreatic cancer model.
    Zhang X, Galardi E, Duquette M, Lawler J, Parangi S.
    Clin Cancer Res; 2005 Aug 01; 11(15):5622-30. PubMed ID: 16061881
    [Abstract] [Full Text] [Related]

  • 31. Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis.
    Prakobwong S, Khoontawad J, Yongvanit P, Pairojkul C, Hiraku Y, Sithithaworn P, Pinlaor P, Aggarwal BB, Pinlaor S.
    Int J Cancer; 2011 Jul 01; 129(1):88-100. PubMed ID: 20824699
    [Abstract] [Full Text] [Related]

  • 32. Gemcitabine-induced apoptosis in 5637 cell line: an in-vitro model for high-risk superficial bladder cancer.
    Gazzaniga P, Silvestri I, Gradilone A, Scarpa S, Morrone S, Gandini O, Gianni W, Frati L, Aglianò AM.
    Anticancer Drugs; 2007 Feb 01; 18(2):179-85. PubMed ID: 17159604
    [Abstract] [Full Text] [Related]

  • 33. 1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models.
    Ma Y, Yu WD, Trump DL, Johnson CS.
    Cancer; 2010 Jul 01; 116(13):3294-303. PubMed ID: 20564622
    [Abstract] [Full Text] [Related]

  • 34. Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model.
    Sung B, Kunnumakkara AB, Sethi G, Anand P, Guha S, Aggarwal BB.
    Mol Cancer Ther; 2009 Apr 01; 8(4):959-70. PubMed ID: 19372569
    [Abstract] [Full Text] [Related]

  • 35. Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine.
    Bocci G, Danesi R, Marangoni G, Fioravanti A, Boggi U, Esposito I, Fasciani A, Boschi E, Campani D, Bevilacqua G, Mosca F, Del Tacca M.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):9-18. PubMed ID: 15363970
    [Abstract] [Full Text] [Related]

  • 36. [Double-mutated oncolytic adenovirus combined with gemcitabine for treating an orthotopic nude mouse model of bladder cancer].
    Wang H, Liu Z, Wang ZP, Li FY, Zhao Y, Chen GP, Li DC.
    Zhonghua Zhong Liu Za Zhi; 2013 Jun 13; 35(6):412-7. PubMed ID: 24119899
    [Abstract] [Full Text] [Related]

  • 37. Enhanced anticancer activity of gemcitabine in combination with noscapine via antiangiogenic and apoptotic pathway against non-small cell lung cancer.
    Chougule MB, Patel A, Sachdeva P, Jackson T, Singh M.
    PLoS One; 2011 Jun 13; 6(11):e27394. PubMed ID: 22102891
    [Abstract] [Full Text] [Related]

  • 38. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
    Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB.
    Mol Pharmacol; 2006 Jan 13; 69(1):195-206. PubMed ID: 16219905
    [Abstract] [Full Text] [Related]

  • 39. Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.
    Ali S, Ahmad A, Banerjee S, Padhye S, Dominiak K, Schaffert JM, Wang Z, Philip PA, Sarkar FH.
    Cancer Res; 2010 May 01; 70(9):3606-17. PubMed ID: 20388782
    [Abstract] [Full Text] [Related]

  • 40. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.
    Bruns CJ, Harbison MT, Davis DW, Portera CA, Tsan R, McConkey DJ, Evans DB, Abbruzzese JL, Hicklin DJ, Radinsky R.
    Clin Cancer Res; 2000 May 01; 6(5):1936-48. PubMed ID: 10815919
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.